临床T1期肾肿块新诊断患者的决策冲突:一项前瞻性研究
本研究基于前瞻性临床试验,对274例新诊断的疑似肾癌临床T1期肾肿块患者进行决策冲突评估。模型估计的平均决策冲突量表(DCS)得分为17.6(95%CI 16.0-19.3),但50%的患者至少一次报告DCS评分≥25。年龄、肿瘤高复杂度、囊性肿块与DCS升高相关,而自我效能、信息寻求行为和患者中心沟通与DCS降低相关。
要点
- 274例入组患者中250例完成DCS调查,74%肿块≤4 cm,11%为高复杂度肿瘤。
- 模型估计的平均DCS得分为17.6(95%CI 16.0-19.3),但50%患者至少一次报告DCS评分≥25。
- 年龄、高复杂度肿瘤和囊性肿块与DCS升高相关,自我效能、信息寻求行为和患者中心沟通与DCS降低相关。
核心结论
- 除患者和临床因素外,决策因素和患者中心沟通与决策冲突相关,突显了更好支持临床T1期肾肿块患者决策的潜在途径。
研究设计与样本
- 从前瞻性临床试验中纳入新诊断的疑似肾癌临床T1期肾肿块患者,在初始决策期两个时间点完成决策冲突量表(DCS),并评估患者人口学、健康状况、肿瘤负荷和患者中心沟通,部分亚队列完成额外决策问卷。
- 使用广义估计方程评估患者、临床和决策因素与DCS评分的关联,以考虑每位患者的重复测量。
主要发现
- 274例入组者中250例完成DCS调查;74%的患者肿块≤4 cm,11%为高复杂度肿瘤。
- 两个时间点模型估计的平均DCS评分为17.6(95%CI 16.0-19.3),但50%的患者至少一次报告DCS评分≥25。
- 多变量分析中,DCS评分随年龄增加(+2.64,95%CI 1.04-4.23)、高复杂度肿瘤 vs 低复杂度肿瘤(+6.50,95%CI 0.35-12.65)和囊性 vs 实性肿块(+9.78,95%CI 5.27-14.28)而升高。
- 决策因素中,DCS评分随自我效能升高(-3.31,95%CI -5.77至-0.86)和信息寻求行为升高(-4.44,95%CI -7.32至-1.56)而降低。
- DCS评分随患者中心沟通评分升高(-8.89,95%CI -11.85至-5.94)而降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Because multiple management options exist for clinical T1 renal masses, patients may experience a state of uncertainty about the course of action to pursue (ie, decisional conflict). To better support patients, we examined patient, clinical, and decision-making factors associated with decisional conflict among patients newly diagnosed with clinical T1 renal masses suspicious for kidney cancer. MATERIALS AND METHODS: From a prospective clinical trial, participants completed the Decisional Conflict Scale (DCS), scored 0 to 100 with < 25 associated with implementing decisions, at 2 time points during the initial decision-making period. The trial further characterized patient demographics, health status, tumor burden, and patient-centered communication, while a subcohort completed additional questionnaires on decision-making. Associations of patient, clinical, and decision-making factors with DCS scores were evaluated using generalized estimating equations to account for repeated measures per patient. RESULTS: Of 274 enrollees, 250 completed a DCS survey; 74% had masses ≤ 4 cm in size, while 11% had high-complexity tumors. Model-based estimated mean DCS score across both time points was 17.6 (95% CI 16.0-19.3), though 50% reported a DCS score ≥ 25 at least once. On multivariable analysis, DCS scores increased with age (+2.64, 95% CI 1.04-4.23), high- vs low-complexity tumors (+6.50, 95% CI 0.35-12.65), and cystic vs solid masses (+9.78, 95% CI 5.27-14.28). Among decision-making factors, DCS scores decreased with higher self-efficacy (-3.31, 95% CI -5.77 to -0.86]) and information-seeking behavior (-4.44, 95% CI -7.32 to -1.56). DCS scores decreased with higher patient-centered communication scores (-8.89, 95% CI -11.85 to -5.94). CONCLUSIONS: In addition to patient and clinical factors, decision-making factors and patient-centered communication relate with decisional conflict, highlighting potential avenues to better support patient decision-making for clinical T1 renal masses.
引用
- Feinberg A, Gessner KH, Deal AM, et al. Decisional Conflict Among Patients Newly Diagnosed With Clinical T1 Renal Masses: A Prospective Study. J Urol. 2024. PMID: 38717916. doi:10.1097/JU.0000000000004023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。